# Transcriptional Framework for the Molecular Diagnosis of Response to Immunotherapy in Lung Cancer With Agnostic Potential

> **NCT06807307** · — · RECRUITING · sponsor: **Regina Elena Cancer Institute** · enrollment: 256 (estimated)

## Conditions studied

- NSCLC

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT06807307
- **Lead sponsor:** Regina Elena Cancer Institute
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** RECRUITING
- **Start date:** 2024-06-04
- **Primary completion:** 2026-06-04
- **Final completion:** 2026-06-04
- **Target enrollment:** 256 (ESTIMATED)
- **Last updated:** 2025-02-04


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06807307

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06807307, "Transcriptional Framework for the Molecular Diagnosis of Response to Immunotherapy in Lung Cancer With Agnostic Potential". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT06807307. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*